February 2, 2017
EA Pharma, a gastroenterology subsidiary of Eisai, said on February 1 that it has filed a new drug application in Japan seeking approval for elobixibat (development code: AJG533), a chronic constipation treatment being jointly developed with Mochida Pharmaceutical. Once approved,...read more